What Medtech Venture Capitalists Want to See in Your Startup

episode

Scott Nelson Live not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Scott Nelson Live

The Hidden Drivers of Clinical Trial Success: Interview with Rivermark CEO Dr. Adam Kadlec 57 min · 16 Dec 2025

Building the Market Before the Product: Interview with Inmedix CEO Andrew Holman, MD 52 min · 10 Dec 2025

All episodes from Scott Nelson Live →

Report any issue

Source

Recorded10 Nov 2020

Publisherfeeds.transistor.fm ↗

Handlerec:13866372

Show notes

This interview is part of a throwback mini-series to several years ago when I chatted with Kevin Bitterman, who at the time, was with Polaris Venture Partners. He’s now a partner with Atlas Venture, but the lessons you can glean from this discussion still hold true. Namely:What medtech venture capitalists like to see in a startup and how these early-stage medical device companies can best position themselves for success. What requirements would make for an attractive IPO opportunity?What questions should medtech startups have already answered before approaching a potential buyer?And in terms of a potential exit, what is more, important for a medical device startup – clinical data or commercial traction?See more...

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.